Afecciones cutáneas relacionadas con Malassezia furfur

Revista Clinica Espanola

Volumn 197, Issue 6, 1997, Pages 420-428

  Aspiroz Sancho M C ^a,c   Saenz De Santamaria M C ^b   Moreno Borraz, L A ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^b HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^c NONE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC DISEASE; DERMATOMYCOSIS; FOLLICULITIS; HUMAN; MALASSEZIA; MICROBIOLOGY; PATHOLOGY; REVIEW; SEBORRHEIC DERMATITIS; SKIN; TINEA VERSICOLOR;

CHRONIC DISEASE; DERMATITIS, SEBORRHEIC; DERMATOMYCOSES; FOLLICULITIS; HUMANS; MALASSEZIA; SKIN; TINEA VERSICOLOR;

EID: 2442708170     PISSN: 00142565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (178)

1. Marcon MJ, Powell DA Human infections due to Malassezia spp Clin Microbiol Rev 1992; 5 101-119
2. Slooff WC Genus 6 Pityrosporum Sabouraud. En: Lodder J, ed. The yeasts A taxonomic study (2nd ed) Amsterdam. North Holland Publishing Co 1970; 1:167-1 186.
3. a ed). Amsterdam: Elsevier Science Publishing Co . 1984; 882-885
4. Faergemann J Epidemiology and ecology of pityriasis versicolor Curr Top Med Mycol 1989; 3:153-167
5. Leeming JP Notman FH, Holland KT, The distribution and ecology of Malassezia furfur and cutaneous bacteria on human skin. J Appl Bacteriol 1989; 67:47-52.
6. Roberts SOB Pityrosporum orbiculare Incidence and distribution on clinically normal skin Br J Dermatol 1969; 81:264-269.
7. Del Palacio A, Moore MK. Pinnasis versicolor y otros procesos superficiales producidos por levaduras lipófilas. En: Torres-Rodriguez JM, Del Palacio-Hernanz A, Guarro-Artigas J, Negroni-Briz R, Pereiro Miguens M, eds Micologia médica Barcelona. Masson SA. 1994; 51-63.
8. Assaf RR, Weil ML, The superficial mycoses. Dermatol Clin 1996; 14:57-67
9. Faergemann J, Pityrosporum infections J Am Acad Dermatol 1994; 31 (suppl 3) S18-S20
10. Quiñones A Tinea versicolor new topical treatments. Cutis 1980; 25:386-388.
11. Bélec L, Testa J, Bouree P. Pityriasis versicolor in the Central African Republic: a randomized study of 144 cases. J Med Vet Mycol 1991; 29:323-329.
12. Lewis MR. Tinea versicolor. Nurse Pract 1986; 11:30-35.
13. Robertson LJ. Itraconazole in the treatment of widespread tinea versicolor. Clin Exp Dermatol 1987; 12:178-180.
14. Forjaz MHH, De Lamonica E, Pinho M, Fischman O, De-Lamonica EM. Pitiríase versicolor. l. Estudo epidemiológico em voluntáries da Universidade Federal de Mato Grosso (Brasil). An Bras Dermatol 1983; 58:249-252.
15. Silva-Lizama E. Tinea versicolor. Int J Dermatol 1995; 34:611-617.
16. Borelli D, Jacobs PH, Nall L. Tinea versicolor: epidemiologic. clinical, and therapeutic aspects. J Am Acad Dermatol 1991; 25:300-305.
17. Faergemann J, Fredriksson T. Tinea versicolor with regard to seborrheic dermatitis. Arch Dermatol 1979; 115:966-968.
18. Hellgren L, Vincent J. The incidence of tinea versicolor in Central Sweden. J Med Microbiol 1983; 16:501-502.
19. Di Silverio A, Mosca M, Brandozzi G, Gatti M. Superficial mycoses observed at the Department of Dermatology of the University of Pavia. Mycopathologia 1989; 105:11-17.
20. Selim MM, Kubec K Pityriasis versicolor. Epidemiogical and therapeutical study. Mycoses 1989; 32:100-103.
21. Imwidthaya S, Thianprasit M. Malassezia furfur in dermatological patients and clinically normal persons J Med Assoc Thai 1988; 71:145-148.
22. Obasi OE. Clayton YM Dermatophyte fungi in the Guinea Savanh Region of Nigena and the changing phase of dermatophytosis in Nigeria. Mycoses 1989; 32 381-385.
23. Abdul Razack EM, Thambiah AS. A clinical study of pityriasis versicolor in Madras Sabouradia 1977; 15:305-311.
24. Perez M, Urbina O, Fernández G, Richard N Influencia de la temperatura y la humedad en la frecuencia de pitiriasis versicolor. Estudio epidemiológico en el Estado Falcón. Venezuela. Invest Clin 1990; 31:121-128.
25. Pontasch MJ, Kyanko ME, Brodell RT. Tinea versicolor of the face in black children in a temperate region. Cutis 1980; 13:81-84.
26. Nanda A, Kaur S, Bhakoo ON, Kaur I, Vaishnavi C. Pityriasis (Tinea) versicolor in infancy Pediatr Dermatol 1988; 5:260-262.
27. Dos reis, A Pinriase versicolor em recém-nascido. Med Cutan Ibero Lat Am 1984; 12:237-238.
28. Smith EB, Gellerman GL. Tinea versicolor in infancy. Arch Dermatol 1966; 93:362-363.
29. Congly H Pityriasis versicolor in a 3-month-old boy. Can Med Assoc J 1984; 130:844-845.
30. Wyre HW, Johnson T. Neonatal pityriasis versicolor. Arch Dermatol 1981; 117 752-753.
31. Akpata LE, Gugnani HC, Snvastava R, Utsalo SJ. Dermatomycoses among industrial workers in Cross River State, Nigeria. Mycoses 1992; 35:371-374.
32. Pereiro M, Pereiro MM, Epidemiología y patogenia de la pitiriasis versicolor Rev Iber Micol 1986; 3:39-46
33. Anzimlt JW, Palmer PH, Woodgyer AJ, Anzimlt DY. A ten year survey of superficial mycoses in the Tauranga District. Bay of Plenty New Zealand Med J 1988; 13:171-174
34. Canteros CE, Davel GO, Vivot W, D Amico S. Incidencia de los distintos agentes etiolõgicos de micosis superficiales. Rev Argent Microbiol 1993; 25:129-135
35. Drake LA, Dinehart SM, Farmer ER. et al Guidelines of care for superficial mycotic infections of the skin J Am Acad Dermatol 1996; 34:287-289
36. Tatnall FM, Rycroft RJG Pityriasis versicolor with cutaneous atrophy induced by topical steroid application Clin Exp Dermatol 1985; 10: 258-261
37. Galadari I, El Komy M. Mousa A, et al. Tinea versicolor: histologic and ultrastructural investigation of pigmentary changes. Int J Dermatol 1992; 31 253-256.
38. Wu YC, Chen KT. Humoral immunity in patients with tinea versicoSor. J Dermatol 1985; 12:161-166.
39. Allen HB, Charles R, Johnson BL. Hyperpigmented tinea versicolor. Arch Dermatol 1976; 112:1.110-1.112.
40. Karaoui R, Bou-Resli M, Al-Zaid NS, Mousa A. Tinea versicolor: ultrastructural studies on hypopigmented and hyperpigmented skin. Dermatologica 1981; 162:69-85.
41. Nazzaro-Porro M, Passi S Identification of tyrosinase inhibitors in cultures of Pityrosporum. J Invest Dermatol 1978; 71:205-208.
42. Nazzaro-Porro M, Passi S, Picardo M, Mercantini R, Breathnach AS. Lipoxygenase activity of Pityrosporum in vitro and in vivo J Invest Dermatol 1986; 87:108-112.
43. Scheynius A, Faergemann J, Forsum U, Sjöberg O. Phenotypic characterization in situ of inflammatory cells in pityriasis (tinea) versicolor. Acta Derm Venereol (Stockh) 1984; 64:473-479
44. Ashbee HR, Ingham E, Holland KT, Cunliffe WJ. Cell-mediated immune responses to Malassezia furfur serovars A, B and C in patients with pitynasis versicolor. seborrheic dermatitis and controls. Exp Dermatol 1994; 3:106-112.
45. Sohnle PG, Collins-Lech C. Analysis of the lymphocyre transformation response to Pityrosporum orbiculare in patients with tinea versicolor. Clin Exp Immunol 1982; 49:559-564.
46. Walters CE, Ingham E, Eady EA, Cove JH, Kearney JN, Cunliffe WJ. In vitro modulation of keratynocite-derived IL-1 β alpha (IL-1 alpha) and peripheral blood mononuclear cell-derived IL-1 beta release in response to cutaneous commensal microorganisms. Infect Immun 1995; 63: 1.223-1.228.
47. Brasch J, Martens H, Sterry W. Langerhans cell acumulation in chronic tinea pedis and pityriasis versicolor. Clin Exp Dermatol 1993; 18:329-332.
48. Ashbee HR, Fruin A, Holland KT, Cunliffe WJ, Ingham E Humoral immunity to Malassezia furfur serovars A, B and C in patients with pityriasis versicolor, seborrheic dermatitis and controls. Exp Dermatol 1994; 3:227-233.
49. DaMert GJ, Kirkpatrick CH, Sohnle P. Comparison of antibody responses in chronic mucocutaneous candidiasis and tinea versicolor. Int Arch Allergy Immunol 1980; 63:97-104.
50. Faergemann J. Antibodies to Prtyrosporum orbiculare in patients with tinea versicolor and controls of various ages. J Invest Dermatol 1983; 80:133-135
51. Johansson S, Faergemann J. Enzyme-linked immunosorbent assay (ELISA) for detection of antibodies against Pityrosporum orbiculare. J Med Veter Mycol 1990; 28:257-260.
52. Faergemann J, Fredriksson T. Experimental infections in rabbits and humans with Pityrosporum orbiculare and P ovate. J Invest Dermatol 1981; 77:314-318.
53. Tosti A, Villardita S, Fazzini ML. The parasitic colonization of the horny layer in tinea versicotor. J Invest Dermatol 1972; 59:233-237.
54. Nazzaro-Porro M, Passi S, Capnlli F, Mercantini R. Induction of hyphae in cultures of Pityrosporum by cholesterol and cholesterol esters. J Invest Dermatol 1977; 69:531-534.
55. Faergemann J, Tjerlund U, Scheynius A, Bernander S. Antigenic similarities and differences in Genus Pityrosporum. J Invest Dermatol 1982; 78:28-31.
56. King RD, Cunico RL, Maibach HI, Greenberg JH, West ML, Jeppsen JC. The effect of occlusion on carbon dioxide emission from human skin. Acta Derm Venereol (Stockh) 1978; 58:135-138.
57. 2, pH, transepidermal water loss, and water content. Arch Dermatol Res 1983; 275:383-387.
58. Faergemann J. Experimental tinea versicolor in rabbits and humans with Pityrosporum orbiculare. J Invest Dermatol 1979; 72:326-329.
59. Burke, RC Tinea versicolor: susceptibility factors and experimental infection in human beings. J Invest Dermatol 1961; 36:389-402
60. Roberts SOB Pityriasis versicolor: a clinical and microbiological investigation. Br J Dermatol 1969; 81:315-326.
61. Chetty GN, Kamalam A, Thambiah, AS. Pityriasis versicolor: a study of 200 cases in a tropical skin clinic. Mykoses 1979; 22:234-246.
62. Hafez M, El-Shamy S. Genetic susceptibility in pityriasis versicolor. Dermatologica 1985; 171:86-88.
63. Kanitakis J, Giannopoulos Z, Tourkantonis A, Kanitakis C. HLA antigens in pitynasis versicolor. Tissue antigens 1984; 23:47-49.
64. Faergemann J, Fredriksson T. Tinea versicolor: some new aspects on etiology, pathogenesis, and treatment Int J Dermatol 1982; 21:8-11.
65. Rezabek GH, Friedman AD. Superficial fungal infections of the skin. Diagnosis and current treatment recommendations. Drugs 1992; 43: 674-682.
66. Galadari I, Abdul Aal J. Epidermodysplasia verruciformis. report of a case with palmar pits. Cutis 1993; 52:53-55.
67. Faergemann J. Aly R. Maibach HI. Growth and filament production of Pityrosporum orbiculare and P ovale on human stratum corneum in vitro Acta Derm Venereol (Stockh) 1983; 63:388-392.
68. Keddie F, Orr A, Liebes D. Direct staining on vinyl plastic tape, demonstration of the cutaneous flora of the epidermis by the strip method. Sabouradia 1961;1:108-111.
69. Di Silverio A, Mosca M, Brandozzi G, Gatti M. Pityriasis versicolor in the aged: a clinical investigation and epidemiological survey in 190 elderiy hospitalized patients Mycopathologia 1989; 195:187-190.
70. Catterall MD. Ketoconazole therapy for pityriasis versicolor. Clin Exp Dermatol 1982; 7:679-681.
71. Clayton YM. Connor BL. Comparison of clotrimazole cream, Whitfield's ointment and Nystatin ointment for the topical treatment of ringworm infections, pityriasis versicolor, erithrasma and canedidiasis. Br J Dermatol 1973 89:297-303.
72. Cauwenbergh GFMJ, Degreef H, Verhoeve LSGC. Topical ketoconazole in dermatology: a pharmacological and clinical review. Mycoses 1984; 27:395-401
73. Savin RC, Horwitz SN. Double-blind comparison of 2% ketoconazole cream and placebo in the treatment of tinea versicolor. J Am Acad Dermatol 1986; 15:500-503
74. Tanenbaum L, Anderson C, Rosenberg MJ, Akers W. 1% Sulconazole cream versus 2% miconazole cream in the treatment of tinea versicolor. Arch Dermatol 1984; 120:216-219.
75. Galimberti RL, Bonino M, Flores V, et al. Ultra short topical treatment of pityriasis versicolor with 2.5% bifonazole cream. Clin Exp Dermatol 1993; 18:25-29.
76. Nasarre J, Umbert P, Herrero E, et al. Therapeutic effect and safety of the new antimycotic sertaconazole in the treatment of pityriasis versicolor. Drug Res 1992; 42:764-767.
77. Crespo V, Marquez M, Torres J, Roset P, Herrero E, Ortiz JA. Ensayo clínico en fase Ill de sertaconazol en solución frente a placebo en el tratamiento de la pitiriasis versicolor. Piel 1993; 8:165-169.
78. Del Palacio A, Guarro J, Figueras-Salvat MJ, Esteban J, Lopez S. Changes in fungal ultrastructure after short-course ciclopiroxolamine therapy in pityriasis versicolor. Clin Exp Dermatol 1990: 15:95-100.
79. Del Palacio A, Delgado S, Menéndez F, Rodriguez-Noriega A, Randomized comparative clinical trial of itraconazole and selenium sulfide shampoo for the treatment of pityriasis versicolor. Rev Infect Dis 1987; 9 (suppl 1):S121-S127.
80. Delescluse J, Cauwenbergh G, Degreef H, Itraconazole, a new orally active antifungal, in the treatment of pityriasis versicolor. Br J Dermatol 1986; 114:701-703.
81. Faergemann J. Treatment of pityriasis versicolor with itraconazole: a double-blind placebo controlled study. Mycoses 1988; 31:377-379.
82. Faergemann J. Treatment of pityriasis versicolor with a single dose of Fluconazole Acta Derm Venereol (Stockh) 1992; 72:74-75.
83. Hay RJ. Yeasts infections. Dermatol Clin 1996; 14:113-124.
84. Faergemann J. Current treatment of cutaneous Pityrosporum and Candida-infections. Acta Derm Venereol (Stockh) 1986; 121 (suppl): 109-116.
85. Bergbrant IM. Seborrhoeic dermatitis and Pityrosporum ovale: cultural, immunological and clinical studies Acta Derm Venereol (Stockh) 1991; 167:1-36
86. Cowley NC, Farr PM, Shuster S. The permisive effect of sebum in seborrhoeic dermatitis: an explanation of the rash in neurological disorders. Br J Dermatol 1990; 122:71-76.
87. O'Neill CJA, Richardson MD, Charlett A, et al. Could seborrhoeic dermatitis be implicated in the pathogenesis of parkinsonism? Acta Neurol Scand 1994; 89:252-257.
88. Hakansson C, Faergemann J, Löwhagen GB. Studies on the lipophilic yeast Pityrosporum ovale in HIV-seropositive and HIV-ssronegative homosexual men. Acta Derm Venereol (Stockh) 1988; 68:422-426.
89. Mathes BM, Douglass MC. Seborrheic dermatitis in patients with acquired immunodeficiency syndrome. J Am Acad Dermatol 1985; 13; 947-951.
90. Ross S, Richardson MD, Graybill JR Association between Malassezia furfur colonization and seborrhoeic dermatitis in AIDS patients. Mycoses 1994; 37:367-370.
91. Schechtman RC, Midgley G, Bingham JS, Hay RJ. Adherence of Malassezia isolates to human keratinocytes in vitro. A study of HIV-positive patients with seborrhoeic dermatitis. Br J Dermatol 1995; 133:537-541.
92. Bergbrant IM, Faergemann J, Voog E, Löwhagen GS. Pityrosporum ovale and seborrhoeic dermatitis in HIV-ssropositive and HIV-seronegative men. Quantitative cultures and serological studies. J Eur Acad Dermatol Venereol 1996; 6:147-151.
93. Soeprono FF, Schinella RA, Cockerell CJ, Comite S. Seborrheic-like dermatitis of acquired immunodeficiency syndrome. A clinicopathologic study. J Am Acad Dermatol 1986; 14:242-248.
94. Wikler JR, Nieboer C, Willemze R. Quantitative skin cultures of Pityrosporum yeasts in patients seropositive for human immunodeficiency virus with and without seborrheic dermatitis. J Am Acad Dermatol 1992; 27:37-39
95. Heng MCY. Henderson CL, Barker DC, Haberfelde G. Correlation of Pityrosporum ovale density with clinical severity of seborrheic dermatitis as assessed by a simplified technique. J Am Acad Dermatol 1990; 23:82-86
96. Croisser D, Bottone EJ, Lebwohl M. Association of Pityrosporum orbiculare (Malassezia furfur) with seborrheic dermatitis in patients with acquired immunodeficiency syndrome (AIDS). J Am Acad Dermatol 1989; 20:770-773.
97. Bergbrant M, Faergemann J. The role of Pityrosporum ovale in seborrhoeic dermatitis. Semin Dermatol 1990; 9:262-268
98. Bergbrant M, Johansson S, Robbins D, et al. The evaluation of various methods and antigens for the detection of antibodies against Pityrosporum ovale in patients with seborrhoeic dermatitis Clin Exp Dermatol 1991; 16:339-343.
99. Sohnle PG, Collins-Lech C. Activation of complement by Pityrosporum orbiculare. J Invest Dermatol 1983; 80:93-97.
100. Schechtman RC, Midgley G, Bingham JS, Hay RJ. Adherence of Malassezia isolates to human keratinocytes in vitro. A study of HIV-positive patients with seborrhoeic dermatitis Br J Dermatol 1995; 133: 537-541.
101. Cuelenaere C, De Bersaques J. Kint A. Use of topical lithium succinate in the treatment of seborrhoeic dermatitis. Dermatology 1992; 184: 194-197.
102. Faergemann J. Seborrhoeic dermatitis and Pityrosporum orbiculare: treatment of seborrhoeic dermatitis of the scalp with miconazole-hydrocortisone (Daktacort). miconazole and hydrocortisone. Br J Dermatol 1986; 114:695-700.
103. Sei Y, Hamaguchi T, Ninomiya J, Nakabayashi A, Takiuchi I. Seborrhoeic dermatitis: treatment with anti-mycotic agents. J Dermatol 1994; 21:334-340.
104. Green CA, Farr PM, Shustar S. Treatment of seborrhoeic dermatitis with ketoconazole: II. Response of seborrhoeic dermatitis of the face, scalp and trunk to topical ketoconazole. Br J Dermatol 1987; 116:217-221.
105. Farr PM, Shuster S. Treatment of seborrhoeic dermatitis with topical ketoconazole. Lancet 1984; 2:1.271-1.272.
106. Zienicke H, Korting HC, Braun-Falco O, et al. Comparative efficacy and safety of bifonazole 1% cream and the corresponding base preparation in the treatment of seborrhoeic dermatitis. Mycoses 1993; 36: 325-331
107. Rigopoulos D, Katsambas A, Antoniou C, Theocharis S, Stratigos J, Facial seborreic dermatitis treated with fluconazole 2% shampoo. Int J Dermatol 1994; 33:136-137.
108. McGrath J, Murphy GM. The control of seborrhoeic dermatitis and dandruff by antipityrosporal drugs. Drugs 1991; 41:178-184.
109. Katsambas A, Antoniou C, Frangouli E, Avgerinou G, Michailidis D, Stratigos J. A double-blind trial of treatment of seborrhoeic dermatitis with 2% ketoconazole cream compared with 1% hidrocortisone cream. Br J Dermatol 1989; 121:353-357.
110. Ford GP, Farr PM, Ive FA, Shuster S. The response of seborrhoeic dermatitis to ketoconazole. Br J Dermatol 1984; 111:603-607.
111. Shuster S. The aetiology of dandruff and the mode of action of therapeutic agents. Br J Dermatol 1984; 111: 235-242.
112. Tooley P. Dandruff: an irritating problem. Practitioner 1990; 234:594-596.
113. McGinley KJ, Leyden JJ, Marples RR, Path MRC, Kligman AM. Quantitative microbiology of the scalp in non-dandruff, dandruff, and seborrheic dermatitis. J Invest Dermatol 1975; 64:401-405.
114. Leyden JJ, McGinley KJ, Kligman AM. Role of microorganisms in dandruff. Arch Dermatol 1976; 112:333-338
115. Marks R, Pearse AD, Walker AP. The effects of a shampoo containing zinc pyrithione on the control of dandruff. Br J Dermatol 1985; 112:415-422.
116. Faergemann J. Propylene glicol in the treatment of seborrheic dermatitis of the scalp: a double-blind study. Cutis 1988; 42:69-71.
117. Wright MC, Hevert F, Rozman T. In vitro comparison of antifungal effects of a coal tar gel and a ketoconazole gel on Malassezia furfur. Mycoses 1993; 36:207-210.
118. Carr MM, Pryce DM, Ive FA. Treatment of seborrhoeic dermatitis with ketoconazolle: I. Response of seborrhoeic dermatitis of the scalp to topical ketoconazole. Br J Dermatol 1987; 116:213-216.
119. Faergemann J. Treatment of seborrhoeic dermatitis of the scalp with ketoconazole shampoo. A double-blind study. Acta Derm Venereol (Stockh) 1990; 70:171-172.
120. Go IH, Wientjens DPWM, Koster M. A Double-blind trial of 1% ketoconazole shampoo versus placebo in the treatment of dandruff. Mycoses 1992; 35:103-105.
121. Segal R, David M, Ingber A, Lurie R, Sardbank M. Treatment with bifonazole shampoo for seborrhea and seborrheic dermatitis: a randomized, double-blind study Acta Derm Venereol (Stockh) 1992; 72:454-455.
122. Bäck O, Faergemann J, Hörnqvist R. Pityrosporum folliculitis: a common disease of the young and middle-aged. Dermatology 1985; 12: 56-61.
123. Ford G, Pityrosporon folliculitis. Int J Dermatol 1984; 23:320-321
124. Teglia O, Schoch PE, Cunha BA. Malassezia furfur infections. Infect Control Hosp Epidemiol 1991; 12:676-681.
125. Bufill JA, Lum LG, Caya JG, et al. Pityrosporum folliculitis after bone marrow transplantation. Clinical observations in five patients Ann Int Med 1988; 108:560-563.
126. Dompmartin D, Drohuet E Folliculites a Pityrosporum ovale. Action de l'econazole. Bull Soc Fr Mycol Med 1977; 6:15-20.
127. Ford GP, Midgley G. Pityrosporum folliculitis and ketoconazote. Br J Dermatol 1982; 107:691-695.
128. Gómez C, Gonzalez A, del Palacio A. et al. Exantema cutáneo en paciente con leucemia linfoblástica aguda. Enferm Infecc Microbiol Clin 1994; 12:411-412.
129. Sandin RL, Fang TT, Hiemenz JW. et al. Malassezia furfur folliculitins in cancer patients. The need for interaction of microbiologists. surgical pathologist, and clinician in facilittating identification by the Clinical Microbiology laboratory. Ann Clin Lab Sci 1993; 23: 377-384.
130. Klotz SA, Malassezia furfur. Infect Dis Clin North Am 1989; 3:53-64.
131. Koranda FC, Dehmel EM, Kahn G, Penn I. Cutaneous complications in immunosuppressed renal homograft recipients. JAMA 1974; 229:419-424
132. Yohn JJ, Lucas J, Camisa C. Malassezia folliculitis in immunocompromised patients Cutis 1985; 35 536-538.
133. Heymann WR, Wolf DJ. Malassezio (Pityrosporon) folliculitis ocurring during pregnancy Int J Dermatol 1986; 25:49-51.
134. Um KB Gram's stained microscopy in the etiological diagnosis of Malassezia (Pityrosporon) folliculitis. Arch Dermatol 1988; 124:492-493
135. Hanna JM. Johnson WT, Wyre HW. Malassezia (Pityrosporum) folliculitis ocurring with granuloma annulare and alopecia areata. Arch Dermatol 1983; 119:869-871.
136. Hjorth N, Sjelin E, Sylvest B, Thomsen K Acne aestivalis. Mallorca acne. Acta Derm Venereol (Stockh) 1972; 52:61-63.
137. Long JG, Keyserling HL Catheter-related infection in infants due to an unusual lipophilic yeast: Malassezia furfur. Pediatrics 1985; 76: 896-900
138. Klotz SA, Drutz DJ, Huppert M. Johnson JE. Pityrosporum folliculitis. Arch Intern Med 1982; 142:2.126-2.129.
139. Potter BS, Burgoon CF, Johnson WC. Pityrosporum folliculitis: report of seven cases and review of the Pityrosporum organism relative to cutaneous disease. Arch Dermatol 1973; 107:388-391.
140. Hill MK, Goodfield MJD, Rodgers FG, Crowley JL, Saihan EM. Skin surface electron microscopy in Pityrosporum folliculitis. Arch Dermatol 1990; 126:181-184.
141. Goodfield MJD, Saihan EM, Crowley J. Experimental folliculitis with Pityrosporum orbiculare: the influence of host response Acta Derm Venereol (Stockh) 1987; 67:445-447.
142. Faergemann J, Johansson S, Bäck O, Scheynius A. An immunologic and cultural study of Pityrosporum folliculitis. J Am Acad Derma-toi 1986; 14:429-433.
143. Faergemann J. Lipophilic yeasts in skin disease. Semin Dermatol 1985; 4:173-184.
144. Yaffee HS. Pityrosporum folliculitis. Arch Dermatol 1973; 108:277.
145. Neumann HAM, Berretty PJM. Treatment of Pityrosporum folliculitis with ketoconazole (R 41400). Mykoses 1981; 24:167-171.
146. Kavanagh GM, Leeming JP, Marshman GM, Reynolds NJ, Burton JL Folliculitis in Down s syndrome. Br J Dermatol 1993; 129:696-699.
147. Gougerot MH. Aspects atypiques de l'acrodermatite continue d'Hallopeau. Bull Soc Fr Derm Syph 1927; 34:719.
148. Gougerot H, Carteaud A. Neue formen der papillomatose. Arch Dermatol Syphilol 1932; 165:232-267.
149. Nagy R, Fairfield J. Confluent and reticulated papillomatosis. Cutis 1982; 29:48-50.
150. Broberg A, Faergemann J. A case of confluent and reticulate papillomatosis (Gougerot-Carteaud) with an unusual location. Acta Derm Venereol (Stockh) 1988; 68:158-160.
151. Kumar AS, Pandhi RK. Syndrome of Carteaud and Gougerot. Case report. Mykosen 1984; 27:313-315.
152. Henning JPH, De Wit RF Familial ocurrence of confluent and reticulated papillomatosis Arch Dermatol 1981; 117:809-810.
153. Nordby CA, Mitchell AJ. Confluent and reticulated papillomatosis responsive to selenium sulfide. Int J Dermatol 1986; 25:194-199.
154. Hamilton D, Tavafoght V, Shafer JC, Hambrick GW. Confluent and reticulated papillomatosis of Gougerot and Carteaud. Its relation with other papillomatoses. J Am Acad Dermatol 1980; 2:401-410.
155. Bruynzeel-Koomen CAFM. Confluent and reticulated papillomatosis succesfully treated with the aromatic etretinate. Arch Dermatol 1984; 120:1.236-1.238.
156. Yesudian P, Kamalam S, Razack A. Confluent and reticulate papillomatosis (Gougerot-Carteaud). Acta Dermato Venereol (Stockh) 1973; 53:381-384
157. Kellet JK, MacDonald RH Confluent and reticulate papillomatosis. Arch Dermatol 1985; 121:587-588
158. Puig L, de Moragas JM. Confluent and reticulated papillomatosis of Gougerot and Carteaud. minocicline deserves trial before etretinate. Arch Dermatol 1995; 131:109-110.
159. Crozier WJ, Wise KA. Onychomycosis due to Pityrosporum. Australas J Dermatol 1993; 34:109-112.
160. Dompmartin D, Dompmartin A, Deluol AM, Grosshans E, Coulaud JP Onychomycosis and AIDS. Int J Dermatol 1990; 29:337-339.
161. Civila ES, Conti IA, Vignale RA, Calegari LF. Onixis por Malassezio (Pityrosporum) ovalis. Med Cutan Ibero Lat Am 1982; 10:343-346.
162. Rosenberg EW, Belew P, Bale G. Effect of topical applications of heavy suspensions of killed Malassezia ovalis on rabbit skin. Mycopathologia 1980; 72:147-154
163. Lober CW, Belew PW, Rosenberg EW, Bale G. Patch test with killed sonicated microflora in patients with psoriasis Arch Dermatol 1982; 118:322-325.
164. Elewski B. Does Pityrosporum ovale have a role in psoriasis? Arch Dermatol 1990; 126:1 111-1.112
165. Rosenberg EW. Belew PW Microbial factors in psoriasis Arch Dermatol 1982; 118:143-144.
166. Belew PW, Lober PW, Marley WM, Bale GF, Rigney SJ, Rosenberg EW Properdin deposition in psoriasis lesions induced by Malassezia ovalis (Pityrosporum ovale) Clin Res 1982; 30:575.
167. Farr PM, Krause LB, Marks JM, Shuster S. Response of scalp to oral ketoconazole. Lancet 1985; 2:921-922.
168. Rosenberg EW, Noah PW, Skinner RB, Zwaag V, West SK, Browder JF. Microbial associations of 167 patients with psoriasis. Acta Derm Venereol (Stockh) 1989; 146 (suppl):S72-S75.
169. Rosenberg EW, Belew PW. Improvement of psoriasis of the scalp with ketoconazote. Arch Dermatol 1982; 118:370-371.
170. Skinner RB, Rosenberg EW, Noah PW. Antimicrobial treatment of psoriasis. Dermatol Clin 1995; 13:909-913.
171. Svejgaard E. The role of microorganisms in atopic dermatitis. Semin Dermatol 1990; 9:255-261.
172. Svejgaard E, Faergeman J, Jemec G, Kieffer M, Ottevanger V Recent investigations on the relationship between fungal skin diseases and atopic dermatitis. Acta Derm Venereol (Stockh) 1989; 144 (suppl):S140-S142.
173. Ring J, Abeck D, Neuber K. Atopic eczema: role of microorganisms on the skin surface Allergy 1992; 47:265-269.
174. Broberg A, Faergemann J, Johansson S, Johansson SGO. Strannergard IL, Svejgaard E. Pityrosporum ovale and atopic dermatitis in children and young adults. Acta Derm Venereol (Stockh) 1992; 72:187-192.
175. Nordvall SL, Johansson S. IgE antibodies to Pityrosporum orbiculare in children with atopic diseases. Acta Paediatr Scand 1990; 79:343-348.
176. Young E, Koers WJ, Berrens L, Intracutaneous test with Pityrosporon extract in atopic dermatitis. Acta Derm Venereol (Stockh) 1989; 144 (suppl):S122-S124.
177. Hjorth N, Clemmensen OJ. Treatment of dermatitis of the head and neck with ketoconazole in patients with type I hypersensitivity for Pityrosporum orbiculare. Semin Dermatol 1983; 2:26-29.
178. Rapelanoro R, Mortureux P, Couprie B, Maleville J, Taïeb A. Neonatal Malassezia furfur pustulosis. Arch Dermatol 1996; 132:190-193.